132 related articles for article (PubMed ID: 27471773)
1. Cytochrome and sulfotransferase gene variation in north African populations.
Fernández-Santander A; Novillo A; Gaibar M; Romero-Lorca A; Moral P; Sánchez-Cuenca D; Amir N; Chaabani H; Harich N; Esteban ME
Pharmacogenomics; 2016 Aug; 17(13):1415-23. PubMed ID: 27471773
[TBL] [Abstract][Full Text] [Related]
2. Sulfation pharmacogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjects.
Carlini EJ; Raftogianis RB; Wood TC; Jin F; Zheng W; Rebbeck TR; Weinshilboum RM
Pharmacogenetics; 2001 Feb; 11(1):57-68. PubMed ID: 11207031
[TBL] [Abstract][Full Text] [Related]
3. Genetic diversity of CYP3A4 and CYP3A5 polymorphisms in North African populations from Morocco and Tunisia.
Novillo A; Romero-Lorca A; Gaibar M; Bahri R; Harich N; Sánchez-Cuenca D; Esteban E; Fernández-Santander A
Int J Biol Markers; 2015 Feb; 30(1):e148-51. PubMed ID: 25385241
[TBL] [Abstract][Full Text] [Related]
4. Genetic diversity of the North African population revealed by the typing of SNPs in the DRD2/ANKK1 genomic region.
Mestiri S; Boussetta S; Pakstis AJ; Elkamel S; Elgaaied ABA; Kidd KK; Cherni L
Gene; 2021 Apr; 777():145466. PubMed ID: 33524518
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of sulfotransferases (SULT1A1 and SULT1A2) in a Turkish population.
Arslan S
Biochem Genet; 2010 Dec; 48(11-12):987-94. PubMed ID: 20936502
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms and linkage disequilibrium of sulfotransferase SULT1A1 and SULT1A2 in a Korean population: comparison of other ethnic groups.
Kim KA; Lee SY; Park PW; Ha JM; Park JY
Eur J Clin Pharmacol; 2005 Nov; 61(10):743-7. PubMed ID: 16133548
[TBL] [Abstract][Full Text] [Related]
7. Y-chromosome DNA haplotypes in north African populations.
Lucotte G; Aouizérate A; Berriche S
Hum Biol; 2000 Jun; 72(3):473-80. PubMed ID: 10885192
[TBL] [Abstract][Full Text] [Related]
8. Genetic contribution to variable human CYP3A-mediated metabolism.
Lamba JK; Lin YS; Schuetz EG; Thummel KE
Adv Drug Deliv Rev; 2002 Nov; 54(10):1271-94. PubMed ID: 12406645
[TBL] [Abstract][Full Text] [Related]
9. The relationship among the polymorphisms of SULT1A1, 1A2 and different types of cancers in Taiwanese.
Peng CT; Chen JC; Yeh KT; Wang YF; Hou MF; Lee TP; Shih MC; Chang JY; Chang JG
Int J Mol Med; 2003 Jan; 11(1):85-9. PubMed ID: 12469224
[TBL] [Abstract][Full Text] [Related]
10. CYP3A4 and CYP3A5 genotyping by Pyrosequencing.
Garsa AA; McLeod HL; Marsh S
BMC Med Genet; 2005 May; 6():19. PubMed ID: 15882469
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of COMT gene polymorphisms in North African populations.
Boussetta S; Cherni L; Pakstis AJ; Ben Salem N; Elkamel S; Khodjet-El-Khil H; Kidd KK; Elgaaied ABA
Gene; 2019 May; 696():186-196. PubMed ID: 30790653
[TBL] [Abstract][Full Text] [Related]
12. CYP3A4-V and prostate cancer in African Americans: causal or confounding association because of population stratification?
Kittles RA; Chen W; Panguluri RK; Ahaghotu C; Jackson A; Adebamowo CA; Griffin R; Williams T; Ukoli F; Adams-Campbell L; Kwagyan J; Isaacs W; Freeman V; Dunston GM
Hum Genet; 2002 Jun; 110(6):553-60. PubMed ID: 12107441
[TBL] [Abstract][Full Text] [Related]
13. STR-based genetic structure of the Berber population of Bejaia (Northern Algeria) and its relationships to various ethnic groups.
Amir N; Sahnoune M; Chikhi L; Atmani D
Gene; 2015 Dec; 574(1):140-8. PubMed ID: 26253162
[TBL] [Abstract][Full Text] [Related]
14. Human Alu insertion polymorphisms in North African populations.
Cherni L; Frigi S; Ennafaa H; Mtiraoui N; Mahjoub T; Benammar-Elgaaied A
Hum Biol; 2011 Oct; 83(5):611-26. PubMed ID: 22146064
[TBL] [Abstract][Full Text] [Related]
15. Association between a CYP3A4 genetic variant and clinical presentation in African-American prostate cancer patients.
Paris PL; Kupelian PA; Hall JM; Williams TL; Levin H; Klein EA; Casey G; Witte JS
Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):901-5. PubMed ID: 10548319
[TBL] [Abstract][Full Text] [Related]
16. CYP3A4 polymorphisms--potential risk factors for breast and prostate cancer: a HuGE review.
Keshava C; McCanlies EC; Weston A
Am J Epidemiol; 2004 Nov; 160(9):825-41. PubMed ID: 15496535
[TBL] [Abstract][Full Text] [Related]
17. Genetic signature consistent with selection against the CYP3A4*1B allele in non-African populations.
Schirmer M; Toliat MR; Haberl M; Suk A; Kamdem LK; Klein K; Brockmöller J; Nürnberg P; Zanger UM; Wojnowski L
Pharmacogenet Genomics; 2006 Jan; 16(1):59-71. PubMed ID: 16344723
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of CYP3A4 polymorphisms in Mexican Amerindian and Mestizo populations.
Reyes-Hernández OD; Lares-Asseff I; Sosa-Macias M; Vega L; Albores A; Elizondo G
Pharmacology; 2008; 81(2):97-103. PubMed ID: 17952011
[TBL] [Abstract][Full Text] [Related]
19. UDP-glucuronosyltransferase genetic variation in North African populations: a comparison with African and European data.
Novillo A; Gaibar M; Romero-Lorca A; Chaabani H; Amir N; Moral P; Esteban ME; Fernández-Santander A
Ann Hum Biol; 2018; 45(6-8):516-523. PubMed ID: 30616396
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population.
Solus JF; Arietta BJ; Harris JR; Sexton DP; Steward JQ; McMunn C; Ihrie P; Mehall JM; Edwards TL; Dawson EP
Pharmacogenomics; 2004 Oct; 5(7):895-931. PubMed ID: 15469410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
